In the first half of 2021, the FDA gave full approval to 343 generic drugs and gave 72 tentative approvals. In the first half of 2020, it gave full approval to 361 generic drugs and gave 92 tentative approvals.
The agency has seen a steady decline in new generic drug sumbisisons from drugmakers, Politico reported. In the first half of this year, the FDA received an average of 66 generic drug submissions per month, down from a high of 94 per month in 2017.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
